Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Significance of Serum L-fucose Glycoprotein as Cancer Biomarker in Head and Neck Malignancies without Distant Metastasis.

Shetty RK, Bhandary SK, Kali A.

J Clin Diagn Res. 2013 Dec;7(12):2818-20. doi: 10.7860/JCDR/2013/6681.3765. Epub 2013 Dec 15.

2.

Correlation of serum levo-fucose levels as a biomarker with tumor node metastasis staging in oral cancer patients.

Manchil PR, Joy ET, Kiran MS, Sherubin JE, Khan MF, Aravind BS.

J Pharm Bioallied Sci. 2016 Oct;8(Suppl 1):S147-S150.

3.

Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.

Parwani RN, Parwani SR.

J Cancer Res Ther. 2011 Apr-Jun;7(2):143-7. doi: 10.4103/0973-1482.82928.

4.

Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.

Rai NP, Anekar J, Shivaraja Shankara YM, Divakar DD, Al Kheraif AA, Ramakrishnaiah R, Sebastian R, Raj AC, Al-Hazmi A, Mustafa SM.

Asian Pac J Cancer Prev. 2015;16(17):7497-500.

5.

Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.

Laryngoscope. 2001 Jun;111(6):1079-87.

PMID:
11404625
6.

Evaluation of serum sialic acid, fucose levels and their ratio in oral squamous cell carcinoma.

Chinnannavar SN, Ashok L, Vidya KC, Setty SM, Narasimha GE, Garg R.

J Int Soc Prev Community Dent. 2015 Nov-Dec;5(6):446-50. doi: 10.4103/2231-0762.169211. Erratum in: J Int Soc Prev Community Dent. 2016 Jul-Aug;6(4):392.

7.

Assessment of serum L-fucose in brain tumor cases.

Manjula S, Monteiro F, Rao Aroor A, Rao S, Annaswamy R, Rao A.

Ann Indian Acad Neurol. 2010 Jan;13(1):33-6. doi: 10.4103/0972-2327.61274.

8.

Evaluation of glycoproteins as prognosticators in head and neck malignancy.

Bathi RJ, Nandimath K, Kannan N, Shetty P.

Indian J Dent Res. 2001 Apr-Jun;12(2):93-9.

PMID:
11665403
9.

Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.

Ozturk B, Coskun U, Sancak B, Yaman E, Buyukberber S, Benekli M.

Int Immunopharmacol. 2009 May;9(5):645-8. doi: 10.1016/j.intimp.2009.02.004. Epub 2009 Feb 26.

PMID:
19249390
10.

Survival from head and neck cancer in Mumbai (Bombay), India.

Yeole BB, Sankaranarayanan R, Sunny M Sc L, Swaminathan R, Parkin DM.

Cancer. 2000 Jul 15;89(2):437-44.

PMID:
10918177
11.

Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.

Imai R, Takenaka Y, Yasui T, Nakahara S, Yamamoto Y, Hanamoto A, Takemoto N, Fukusumi T, Cho H, Yamamoto M, Inohara H.

Acta Otolaryngol. 2015 Mar;135(3):295-301. doi: 10.3109/00016489.2014.951454. Epub 2015 Jan 26.

PMID:
25622661
12.

Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.

Szewczyk M, Pazdrowski J, Golusiński P, Dańczak-Pazdrowska A, Marszałek S, Golusiński W.

Eur Arch Otorhinolaryngol. 2015 Oct;272(10):3007-12. doi: 10.1007/s00405-014-3261-6. Epub 2014 Sep 13.

13.

Role of serum ß-carotene in the diagnosis and prevention of oral squamous cell carcinoma - a case control study.

Chippagiri P, Im A, Banavar SR.

J Clin Diagn Res. 2014 Apr;8(4):ZC01-3. doi: 10.7860/JCDR/2014/7534.4211. Epub 2014 Apr 15.

14.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

15.

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.

Arem H, Weinstein SJ, Horst RL, Virtamo J, Yu K, Albanes D, Abnet CC.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1178-84. doi: 10.1158/1055-9965.EPI-11-0153. Epub 2011 Apr 28.

16.

Prevalence of level V metastasis in head and neck squamous cell carcinoma.

Kainuma K, Yano T, Kitoh R, Naito T, Usami S.

Acta Otolaryngol. 2013 Feb;133(2):218-24. doi: 10.3109/00016489.2012.726742. Epub 2012 Nov 13.

PMID:
23145939
17.

Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.

Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB.

Radiother Oncol. 2000 May;55(2):121-9.

PMID:
10799723
18.
19.

Thallium-201 SPECT in the diagnosis of head and neck cancer.

Valdés Olmos RA, Balm AJ, Hilgers FJ, Koops W, Loftus BM, Tan IB, Muller SH, Hoefnagel CA, Gregor RT.

J Nucl Med. 1997 Jun;38(6):873-9.

20.

Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience.

Osman N, Elamin YY, Rafee S, O'Brien C, Stassen LF, Timon C, Kinsella J, Brennan S, O'Byrne KJ.

Eur Arch Otorhinolaryngol. 2014 Aug;271(8):2253-9.

PMID:
24121822

Supplemental Content

Support Center